We further demonstrated that the reduced expression of YOD1 was caused by overexpression of miR-221/222 and revealed that YOD1 overexpression augments the inhibitory effects of FLT3 tyrosine kinase inhibitors (TKIs) in AML cells. This evidence concerns the gene YOD1 and acute myeloid leukemia.